Mirae Asset Global Investments’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $212K | Buy |
+14,616
| New | +$197K | ﹤0.01% | 1111 |
|
|
2026
Q1 | – | Sell |
-21,580
| Closed | -$303K | – | 1710 |
|
|
2025
Q4 | $303K | Buy |
21,580
+374
| +2% | +$5.25K | ﹤0.01% | 1090 |
|
|
2025
Q3 | $296K | Sell |
21,206
-162
| -0.8% | -$2.33K | ﹤0.01% | 1078 |
|
|
2025
Q2 | $321K | Buy |
21,368
+1,542
| +8% | +$22K | ﹤0.01% | 993 |
|
|
2025
Q1 | $262K | Buy |
19,826
+1,160
| +6% | +$16K | ﹤0.01% | 1009 |
|
|
2024
Q4 | $293K | Sell |
18,666
-664
| -3% | -$9.97K | ﹤0.01% | 1008 |
|
|
2024
Q3 | $308K | Sell |
19,330
-8,065
| -29% | -$130K | ﹤0.01% | 1018 |
|
|
2024
Q2 | $413K | Buy |
+27,395
| New | +$393K | ﹤0.01% | 944 |
|
|
2023
Q2 | – | Sell |
-52,420
| Closed | -$597K | – | 2675 |
|
|
2023
Q1 | $597K | Buy |
+52,420
| New | +$566K | ﹤0.01% | 1838 |
|
|
2021
Q4 | – | Sell |
-27,525
| Closed | -$359K | – | 1724 |
|
|
2021
Q3 | $359K | Buy |
27,525
+3,880
| +16% | +$51.7K | ﹤0.01% | 1571 |
|
|
2021
Q2 | $348K | Buy |
23,645
+4,885
| +26% | +$68.3K | ﹤0.01% | 1551 |
|
|
2021
Q1 | $230K | Sell |
18,760
-18,420
| -50% | -$237K | ﹤0.01% | 1476 |
|
|
2020
Q4 | $530K | Buy |
37,180
+1,770
| +5% | +$23.8K | ﹤0.01% | 1290 |
|
|
2020
Q3 | $493K | Buy |
35,410
+5,305
| +18% | +$63.2K | ﹤0.01% | 1191 |
|
|
2020
Q2 | $319K | Sell |
30,105
-4,485
| -13% | -$45.6K | ﹤0.01% | 1281 |
|
|
2020
Q1 | $279K | Sell |
34,590
-6,020
| -15% | -$50.2K | ﹤0.01% | 1215 |
|
|
2019
Q4 | $330K | Sell |
40,610
-820
| -2% | -$6.48K | ﹤0.01% | 1331 |
|
|
2019
Q3 | $314K | Sell |
41,430
-965
| -2% | -$7.18K | ﹤0.01% | 1303 |
|
|
2019
Q2 | $318K | Buy |
+42,395
| New | +$333K | ﹤0.01% | 1268 |
|
|
2017
Q1 | – | Sell |
-45,795
| Closed | -$415K | – | 664 |
|
|
2016
Q4 | $415K | Buy |
45,795
+7,190
| +19% | +$66.9K | 0.01% | 420 |
|
|
2016
Q3 | $358K | Buy |
38,605
+2,960
| +8% | +$28.3K | 0.01% | 479 |
|
|
2016
Q2 | $366K | Buy |
+35,645
| New | +$327K | 0.01% | 438 |
|
|
2015
Q4 | – | Sell |
-17,575
| Closed | -$225K | – | 476 |
|
|
2015
Q3 | $225K | Sell |
17,575
-1,385
| -7% | -$17.2K | 0.01% | 405 |
|
|
2015
Q2 | $209K | Sell |
18,960
-945
| -5% | -$10.4K | 0.01% | 446 |
|
|
2015
Q1 | $227K | Buy |
+19,905
| New | +$211K | 0.01% | 440 |
|
|
2014
Q4 | – | Sell |
-28,770
| Closed | -$302K | – | 464 |
|
|
2014
Q3 | $302K | Buy |
28,770
+5,225
| +22% | +$49.1K | 0.01% | 406 |
|
|
2014
Q2 | $203K | Buy |
+23,545
| New | +$198K | ﹤0.01% | 403 |
|
|
2013
Q3 | – | Sell |
-28,055
| Closed | -$212K | – | 437 |
|
|
2013
Q2 | $212K | Buy |
+28,055
| New | +$205K | 0.01% | 389 |
|
Other funds holding RDY
QC
AIM
Mirae Asset Global Investments's RDY Position: Q2 2026 in Review
Mirae Asset Global Investments opened a new position in Dr. Reddy's Laboratories (RDY) in Q2 2026: 14,616 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #1111 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in RDY as recently as Q4 2025.
Mirae Asset Global Investments first reported a position in RDY in Q2 2013 and has held it in 28 quarters since. The position peaked at $597K in Q1 2023. 102 funds tracked by Wall St. Rank hold RDY as of Q2 2026.
- Mirae Asset Global Investments held 14,616 shares of Dr. Reddy's Laboratories worth $212K as of Q2 2026.
- Dr. Reddy's Laboratories was a new Mirae Asset Global Investments position in Q2 2026.
- Dr. Reddy's Laboratories made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1111 holding.
- Mirae Asset Global Investments first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 28 quarters since.
- Mirae Asset Global Investments's Dr. Reddy's Laboratories position peaked at $597K in Q1 2023.
- 102 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.